FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 33 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,513,535 | -3.2% | 582,129 | +74.0% | 0.00% | 0.0% |
| Q2 2023 | $1,563,570 | +106193.0% | 334,577 | -17.1% | 0.00% | 0.0% |
| Q1 2023 | $1,471 | -94.9% | 403,788 | +3344.7% | 0.00% | – |
| Q2 2022 | $29,000 | -86.4% | 11,722 | -56.5% | 0.00% | – |
| Q3 2021 | $213,000 | +85.2% | 26,925 | +151.0% | 0.00% | – |
| Q1 2021 | $115,000 | -78.9% | 10,726 | -76.9% | 0.00% | – |
| Q4 2020 | $546,000 | -75.1% | 46,510 | -74.5% | 0.00% | -100.0% |
| Q3 2020 | $2,196,000 | -40.3% | 182,712 | -13.2% | 0.00% | -40.0% |
| Q2 2020 | $3,677,000 | – | 210,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |